GW597599 + ondansetron

GW597599 + ondansetron is a combination drug consisting of GW597599 (a code name for an experimental compound, details of which are limited and not provided in the search results) and ondansetron, a selective serotonin 5-HT3 receptor antagonist widely used for the prevention and treatment of nausea and vomiting induced by chemotherapy, radiotherapy, or surgery. In such combinations, each agent acts via its specific mechanism—ondansetron antagonizes the 5-HT3 receptor primarily peripherally at vagal nerve terminals and centrally in the area postrema, preventing emesis, while GW597599’s exact mechanism is unspecified in accessible literature. The combination drug is presumably being explored for enhanced or broader-spectrum antiemetic efficacy.

Brand names

ZofranZuplenz